Jim Cramer Says "UnitedHealth Has Got A Lot of Good Things Going for It"

UnitedHealth Group Incorporated (NYSE:UNH) is one of the stocks Jim Cramer expressed his thoughts on. A caller asked for Cramer’s opinion of the stock, and he replied:

“I’m a buyer. What happened in UnitedHealth, where they did some, where there was some chicanery, seems to be the, the authorities don’t seem to be looking at that. UnitedHealth has got a lot of good things going for it. This may not be the year that it turns around, but I do think next year it will. I’ve looked at it hard. Now, my favorite, by the way, is CVS… because they’ve got another model, front of the store that is real good too.”

UnitedHealth Group Incorporated (NYSE:UNH) provides health care services, insurance plans, pharmacy care, and data-driven solutions. During the September 18 episode, Cramer said that he would buy the stock with calls and not buy common stock. He commented:

“Okay, so UNH, when I read that they are throwing their weight around in Washington and spending a lot of time with the, in the executive offices and really spending a, really making a point of touching bases with all the people who might be able to rub up against some of the people who are trying to hurt them, like maybe prosecutors, it makes me feel that UNH is bottomed. And I did think that they would be, they could have the death sentence of being investigated for Medicare fraud. It does seem like that might be off the table. I don’t, do I want to go buy it here? I would, if I bought it, I would buy with calls. I would not buy with common stock.”

While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.